Skip to content
  • Sunday, 26 July 2026
  • 2:58 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • A New Two-Component Dark Matter Model Explains the Galactic Center Gamma-Ray Excess While Reconciling the Absence of Signals in Dwarf Galaxies
Advanced Materials Science

A New Two-Component Dark Matter Model Explains the Galactic Center Gamma-Ray Excess While Reconciling the Absence of Signals in Dwarf Galaxies

Nila Kartika Wati May 4, 2026 0

The search for dark matter, the invisible substance believed to constitute approximately 85% of the matter in the universe, has…

Read More
Advanced Materials Science

Two-Component Dark Matter Models and the Galactic Center Gamma-Ray Excess: Reconciling the Silence of Dwarf Galaxies

Nila Kartika Wati Apr 11, 2026 0

The pursuit of dark matter remains one of the most formidable challenges in modern astrophysics, as this elusive substance constitutes…

Read More
Pharma 50: The 50 best-selling drugs of FY2025Unveiling the Ancient Architects of Plant Life: Breakthroughs in Deep Time Genetics Reveal Enduring Regulatory DNALudwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous LeukemiaUnveiling Earth’s Hidden Infrastructure: First Global Maps Detail Vast Underground Fungal Networks Essential for Climate Regulation
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ